Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2010-06-30
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to investigate the relationship between traffic-related air pollution exposure, and respiratory and cardiovascular health impacts in commuting cyclists. Specifically, the investigators propose to:
1. determine commuting cyclists' exposure to traffic-related air pollutants (PM 2.5, PM10, ultrafine particulate, black carbon) while cycling along two different bicycle routes in the city of Vancouver;
2. estimate the pollutant dose received by each cyclist, and relate this to the health effects observed; and
3. determine if there is a change in lung function, endothelial function, and C-reactive protein level related to the level of air pollution exposure and dose
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal cycling
Cycling on a residential and downtown route (crossover design)
Cycling on a residential route
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cycling on a residential route
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male or female
* able to bicycle comfortably on city streets for 1 hour
Exclusion Criteria
* Must be of height to safely ride a test bike (\<5'2", \>6'5" )
* Diagnosed asthma or active allergy (hav fever) symptoms
* Irregular menstrual cycle, pregnant, breastfeeding, non-monocyclic contraceptive medication or device
* Taking medication for heart or lung condition
* Answers yes to any questions on physical activity readiness questionnaire (PAR-Q)
* requires pain medication daily
* visual or hearing impairment that prevents safe cycling on streets with motor vehicles
19 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Brauer, ScD
Role: PRINCIPAL_INVESTIGATOR
The University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Air Pollution Exposure Lab, Vancouver General Hospital through the School of Population and Public Health, University of British Columbia
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cole CA, Carlsten C, Koehle M, Brauer M. Particulate matter exposure and health impacts of urban cyclists: a randomized crossover study. Environ Health. 2018 Nov 14;17(1):78. doi: 10.1186/s12940-018-0424-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H1008-111481/001/XSB
Identifier Type: OTHER
Identifier Source: secondary_id
H10-00902
Identifier Type: -
Identifier Source: org_study_id